B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Report

Global and Region B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：156
  • REPORT CODE：GMM929386
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of B-Cell Maturation Antigen(BCMA) Targeted Therapies market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapiesmarket, defines the market attractiveness level of B-Cell Maturation Antigen(BCMA) Targeted Therapies market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of B-Cell Maturation Antigen(BCMA) Targeted Therapies industry, describes the types of B-Cell Maturation Antigen(BCMA) Targeted Therapies market, the applications of major players and the market size, and deeply analyzes the current situation of the global B-Cell Maturation Antigen(BCMA) Targeted Therapies market and the development prospects and opportunities of B-Cell Maturation Antigen(BCMA) Targeted Therapies industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global B-Cell Maturation Antigen(BCMA) Targeted Therapies market in Chapter 13.

    By Player:

    • Credit Suisse Securities

    • firstVentury Equity

    • Deerfield Partners

    • Sutro Biopharma

    • Malin Corporation

    • Five Prime Therapeutics

    • Onyx Pharmaceuticals

    • Juno Therapeutics

    • Dana-Farber Cancer Institute

    • Eureka Therapeutics

    • Transposagen Biopharmaceuticals

    By Type:

    • Bispecific Antibodies

    • Antibody Drug Conjugates

    • Chimeric Antigen Receptor T-Cells

    By End-User:

    • Liver Cancer

    • Respiratory Cancer

    • Brain Cancer

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis and Outlook to 2022

    • 7.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)

    • 7.2 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)

    • 7.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)

    • 7.4 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)

    • 7.5 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)

    • 7.6 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)

    • 7.7 South Korea B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)

    8 Region and Country-wise B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis and Outlook to 2028

    • 8.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)

    • 8.2 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)

    • 8.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)

    • 8.4 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)

    • 8.5 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)

    • 8.6 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)

    • 8.7 South Korea B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)

    9 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Outlook by Types and Applications to 2022

    • 9.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Bispecific Antibodies Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Antibody Drug Conjugates Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Chimeric Antigen Receptor T-Cells Consumption and Growth Rate (2017-2022)

    • 9.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Liver Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Respiratory Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Brain Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Outlook by Types and Applications to 2028

    • 10.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Bispecific Antibodies Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Antibody Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Chimeric Antigen Receptor T-Cells Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Liver Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Respiratory Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Brain Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Import and Export Analysis (Top 5 Countries)

    • 11.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Competitive Analysis

    • 14.1 Credit Suisse Securities

      • 14.1.1 Credit Suisse Securities Company Details

      • 14.1.2 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • 14.2 firstVentury Equity

      • 14.2.1 firstVentury Equity Company Details

      • 14.2.2 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • 14.3 Deerfield Partners

      • 14.3.1 Deerfield Partners Company Details

      • 14.3.2 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • 14.4 Sutro Biopharma

      • 14.4.1 Sutro Biopharma Company Details

      • 14.4.2 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • 14.5 Malin Corporation

      • 14.5.1 Malin Corporation Company Details

      • 14.5.2 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • 14.6 Five Prime Therapeutics

      • 14.6.1 Five Prime Therapeutics Company Details

      • 14.6.2 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • 14.7 Onyx Pharmaceuticals

      • 14.7.1 Onyx Pharmaceuticals Company Details

      • 14.7.2 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • 14.8 Juno Therapeutics

      • 14.8.1 Juno Therapeutics Company Details

      • 14.8.2 Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • 14.9 Dana-Farber Cancer Institute

      • 14.9.1 Dana-Farber Cancer Institute Company Details

      • 14.9.2 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • 14.10 Eureka Therapeutics

      • 14.10.1 Eureka Therapeutics Company Details

      • 14.10.2 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • 14.11 Transposagen Biopharmaceuticals

      • 14.11.1 Transposagen Biopharmaceuticals Company Details

      • 14.11.2 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of B-Cell Maturation Antigen(BCMA) Targeted Therapies

    • Figure B-Cell Maturation Antigen(BCMA) Targeted Therapies Picture

    • Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Country (2017-2022)

    • Figure United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)

    • Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)

    • Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)

    • Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)

    • Figure South Korea B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)

    • Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast by Country (2022-2028)

    • Figure United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bispecific Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global Antibody Drug Conjugates Consumption and Growth Rate (2017-2022)

    • Figure Global Chimeric Antigen Receptor T-Cells Consumption and Growth Rate (2017-2022)

    • Figure Global Liver Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Respiratory Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Brain Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Bispecific Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antibody Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chimeric Antigen Receptor T-Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liver Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Respiratory Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Brain Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Import by Region (Top 5 Countries) (2017-2028)

    • Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Export by Region (Top 5 Countries) (2017-2028)

    • Table Credit Suisse Securities (Foundation Year, Company Profile and etc.)

    • Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • Table firstVentury Equity (Foundation Year, Company Profile and etc.)

    • Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • Table Deerfield Partners (Foundation Year, Company Profile and etc.)

    • Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • Table Sutro Biopharma (Foundation Year, Company Profile and etc.)

    • Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • Table Malin Corporation (Foundation Year, Company Profile and etc.)

    • Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • Table Five Prime Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • Table Onyx Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • Table Juno Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • Table Dana-Farber Cancer Institute (Foundation Year, Company Profile and etc.)

    • Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • Table Eureka Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service

    • Table Transposagen Biopharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US